Company intelligence / Profile preview

Gene Solutions

Ho Chi Minh City, Vietnamgenesolutions.com ↗

Ownership: Private
Employees: ~100
Development stage: Commercial

Overview

Gene Solutions has developed and commercialized multiple genetic testing products including non-invasive prenatal testing (NIPT), multi-cancer early detection via liquid biopsy, and actionable mutation tests to support targeted therapies. Their SPOT-MAS test has undergone clinical validation. The company reports supporting over eight thousand people in Vietnam with free early cancer screening as of late 2022.

Therapeutic areas: OncologyRare DiseasesWomen's Health
Modalities: Next-generation sequencing (NGS)Cell-free DNA technologyLiquid biopsyGenetic testing services (platform-based)
Industry: Molecular Diagnostics

Partnerships

Mekong Capital identified as a key investor/partner.

Beyond the preview

Go deeper on Gene Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gene Solutions.

Explore the full profile